86
Participants
Start Date
June 6, 2023
Primary Completion Date
August 22, 2024
Study Completion Date
January 9, 2025
SAR442970
1 mL extractable volume of 150 mg/mL SAR442970 filled in 2 mL glass vial
Placebo
1 mL extractable volume of placebo filled in 2 mL glass vial
Investigational Site Number : 0560002, Woluwe-Saint-Lambert
Investigational Site Number : 0360005, Westmead
Investigational Site Number : 0360002, Liverpool
Investigational Site Number : 0560001, Leuven
Investigational Site Number : 0360001, Carlton
Investigational Site Number : 2080001, Roskilde
Investigational Site Number : 0360003, Woolloongabba
Investigational Site Number : 2030001, Prague
Investigational Site Number : 2760005, Berlin
Investigational Site Number : 3000003, Athens
Investigational Site Number : 7240005, Córdoba
Investigational Site Number : 2030002, Praha 5 - Motol
Investigational Site Number : 3000001, Athens
Investigational Site Number : 3800002, Rozzano
Investigational Site Number : 3800001, Milan
Investigational Site Number : 7240001, Madrid / Madrid
Investigational Site Number : 7240006, Madrid
Advanced Medical Research PC Site Number : 8400002, Sandy Springs
ForCare Clinical Research Site Number : 8400006, Tampa
Renstar Medical Research Site Number : 8400011, Ocala
Investigational Site Number : 2760008, Bochum
Investigational Site Number : 7240004, Manises
Investigational Site Number : 2760001, Münster
Investigational Site Number : 2500003, Reims
Investigational Site Number : 2760004, Mainz
Investigational Site Number : 2760002, Frankfurt am Main
Investigational Site Number : 2500001, Lyon
Investigational Site Number : 2030003, Ostrava - Poruba
Center for Clinical Studies, LTD. LLP Site Number : 8400003, Houston
Medical Dermatology Specialists Site Number : 8400007, Phoenix
Investigational Site Number : 6160004, Lodz
Investigational Site Number : 2500004, Saint-Mandé
Investigational Site Number : 3800003, Catania
Investigational Site Number : 1520003, Santiago
Investigational Site Number : 1520001, Santiago
Investigational Site Number : 1520002, Santiago
Clinical Partners, LLC Site Number : 8400010, Johnston
Investigational Site Number : 1240001, Barrie
Investigational Site Number : 1240002, London
Investigational Site Number : 1240004, Newmarket
Investigational Site Number : 1240007, Québec
Investigational Site Number : 2500002, Nice
Investigational Site Number : 5280002, Breda
Investigational Site Number : 5280001, Groningen
Investigational Site Number : 5280003, Rotterdam
Investigational Site Number : 6160001, Warsaw
Investigational Site Number : 6160003, Wroclaw
Investigational Site Number : 6160002, Wroclaw
Investigational Site Number : 7240003, Barcelona
Investigational Site Number : 7520001, Älvsjö
Lead Sponsor
Sanofi
INDUSTRY